John G. Ullman & Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-78,762
| Closed | -$9.11M | – | 184 |
|
|
2023
Q3 | $9.11M | Sell |
78,762
-950
| -1% | -$102K | 1.49% | 18 |
|
|
2023
Q2 | $8.2M | Sell |
79,712
-2,275
| -3% | -$240K | 1.26% | 20 |
|
|
2023
Q1 | $8.95M | Sell |
81,987
-1,375
| -2% | -$152K | 1.39% | 19 |
|
|
2022
Q4 | $9.49M | Sell |
83,362
-4,640
| -5% | -$385K | 1.51% | 17 |
|
|
2022
Q3 | $5.45M | Buy |
88,002
+2,500
| +3% | +$175K | 0.95% | 33 |
|
|
2022
Q2 | $6.82M | Buy |
85,502
+18,600
| +28% | +$1.76M | 1.09% | 29 |
|
|
2022
Q1 | $7.04M | Sell |
66,902
-1,625
| -2% | -$158K | 0.98% | 33 |
|
|
2021
Q4 | $7.38M | Sell |
68,527
-850
| -1% | -$92.7K | 1.02% | 33 |
|
|
2021
Q3 | $7.6M | Sell |
69,377
-767
| -1% | -$79.6K | 1.03% | 37 |
|
|
2021
Q2 | $6.57M | Sell |
70,144
-2,183
| -3% | -$201K | 0.86% | 37 |
|
|
2021
Q1 | $6.66M | Sell |
72,327
-3,200
| -4% | -$270K | 0.89% | 37 |
|
|
2020
Q4 | $5.53M | Sell |
75,527
-925
| -1% | -$68.8K | 0.86% | 42 |
|
|
2020
Q3 | $5.94M | Sell |
76,452
-400
| -0.5% | -$27.5K | 1.23% | 29 |
|
|
2020
Q2 | $4.27M | Sell |
76,852
-200
| -0.3% | -$8.56K | 1.04% | 30 |
|
|
2020
Q1 | $2.28M | Sell |
77,052
-1,300
| -2% | -$44K | 0.61% | 44 |
|
|
2019
Q4 | $2.84M | Sell |
78,352
-1,200
| -2% | -$36.8K | 0.49% | 58 |
|
|
2019
Q3 | $2.17M | Buy |
+79,552
| New | +$2.06M | 0.39% | 59 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB